29 patents
Utility
Methods of treating AL amyloidosis
4 Jul 23
Antibody formulations and methods useful for treatment of patients with AL amyloidosis.
Gene Kinney, Carol Karp, Wagner Marcelo Zago, Radhika Tripuraneni
Filed: 5 Mar 20
Utility
Tau immunotherapy
9 May 23
The invention provides antibodies to tau.
Peter Seubert, Philip James Dolan, III, Yue Liu, Robin Barbour
Filed: 29 Oct 19
Utility
Antibodies recognizing tau
21 Feb 23
The invention provides antibodies that specifically bind tau.
Robin Barbour, Philip James Dolan, III, Yue Liu, Svetlana Alexander, Mark E. Renz
Filed: 4 Nov 20
Utility
Tau immunotherapy
8 Nov 22
The invention provides antibodies to tau.
Peter Seubert, Philip James Dolan, III, Yue Liu, Robin Barbour
Filed: 20 Jul 20
Utility
Anti-abeta antibodies
13 Sep 22
Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
Michael Skov, Tarlochan S. Nijjar, Frédérique Bard, Robin Barbour, Wagner Zago
Filed: 20 Apr 22
Utility
Anti-abeta antibodies
6 Sep 22
Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
Michael Skov, Tarlochan S. Nijjar, Frédérique Bard, Robin Barbour, Wagner Zago
Filed: 25 Oct 21
Utility
Anti-Abeta antibodies
6 Sep 22
Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
Michael Skov, Tarlochan S. Nijjar, Frédérique Bard, Robin Barbour, Wagner Zago
Filed: 25 Oct 21
Utility
Anti-Abeta antibodies
6 Sep 22
Antibodies that bind human beta-amyloid peptide, methods of detecting, measuring and treating amyloidogenic disorders with said antibodies, pharmaceutical compositions comprising the antibodies and methods of manufacture are provided.
Michael Skov, Tarlochan S. Nijjar, Frédérique Bard, Robin Barbour, Wagner Zago
Filed: 25 Oct 21
Utility
Humanized antibodies that recognize alpha-synuclein
31 May 22
The present application discloses humanized 9E4 antibodies.
Jose William Saldanha, Tarlochan S. Nijjar
Filed: 16 Jun 20
Utility
Anti-transthyretin antibodies
8 Mar 22
The invention provides antibodies that specifically bind to transthyretin (TTR).
Joshua Reginald Salmans, Svetlana Alexander, Robin Barbour, Jeffrey N. Higaki, Tarlochan S. Nijjar
Filed: 5 Oct 18
Utility
Infrared assay detecting secondary structure profiles of alpha-synuclein
1 Feb 22
The invention provides an infrared assay which allows the secondary structure analysis of alpha-synuclein from complex fluids like serum, blood plasma or cerebrospinal fluid without prior isolation, concentration or pretreatment.
Robin Barbour
Filed: 1 Dec 17
Utility
Monitoring immunotherapy of Lewy body disease from constipation symptoms
7 Dec 21
The invention provides methods of monitoring immunotherapy directed against alpha-synuclein by comparing a subject's constipation symptoms before treatment and at one or more times during and/or after treatment.
Gene G. Kinney, Theresa Anne Neumann, Daniel Keith Ness
Filed: 19 Nov 14
Utility
Anti-transthyretin antibodies
8 Jun 21
The invention provides antibodies that specifically bind transthyretin (TTR).
Yue Liu, Tarlochan S. Nijjar, Avijit Chakrabartty, Jeffrey N. Higaki
Filed: 26 Sep 19
Utility
Antibodies recognizing tau
30 Mar 21
The invention provides antibodies that specifically bind tau.
Tarlochan S. Nijjar, Robin Barbour, Philip James Dolan, III, Yue Liu, Svetlana Alexander, Mark E. Renz
Filed: 3 Mar 20
Utility
Antibodies recognizing tau
2 Feb 21
The invention provides antibodies that specifically bind tau.
Robin Barbour, Philip James Dolan, III, Yue Liu
Filed: 2 May 17
Utility
Anti-transthyretin antibodies
2 Feb 21
The invention provides antibodies that specifically bind to transthyretin (TTR).
Tarlochan S. Nijjar, Avijit Chakrabartty, Jeffrey N. Higaki
Filed: 30 Oct 19
Utility
Anti-Laminin4 antibodies specific for LG4-5
12 Jan 21
The invention provides antibodies that specifically bind to the LG4-5 modules of the G domain of laminin α4.
Stephen Jed Tam, Yue Liu, Robin Barbour, Theodore Yednock, Kenneth Flanagan
Filed: 12 Mar 18
Utility
Antibodies recognizing tau
12 Jan 21
The invention provides antibodies that specifically bind tau.
Robin Barbour, Philip James Dolan, III, Yue Liu, Svetlana Alexander, Mark E. Renz
Filed: 2 May 17
Utility
Humanized antibodies that recognize alpha-synuclein
28 Dec 20
The present application discloses humanized 1H7 antibodies.
Jose Saldanha, Tarlochan S. Nijjar
Filed: 18 Feb 20
Utility
Antibodies recognizing alpha-synuclein
28 Dec 20
The invention provides monoclonal antibody 5C1 and related antibodies.
Robin Barbour, Kate Dora Games Thiel, Tarlochan S. Nijjar
Filed: 22 Apr 20